强力新材 reported revenue of ¥0.54B for the period ended 2026-06-30, +17.1% year on year. Net income was ¥-0.06B, a -11.5% net margin on a 18.9% gross margin. The largest revenue line is 其他用途光引发剂 at 28% of the total. Free cash flow for the period was ¥0.03B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.54B | +17.1% |
| Gross profit | ¥0.10B | — |
| Operating income | ¥-0.06B | — |
| Net income | ¥-0.06B | — |
| Gross margin | 18.9% | Net margin -11.5% |
| Revenue Q/Q | +13.9% | — |
| Segment | Revenue | Share |
|---|---|---|
| 其他用途光引发剂 | ¥0.15B | 27.8% |
| PCB光刻胶光引发剂 | ¥0.09B | 16.2% |
| LCD光刻胶光引发剂 | ¥0.08B | 15.5% |
| 化工原料贸易 | ¥0.08B | 14.8% |
| PCB光刻胶树脂 | ¥0.06B | 11.4% |
| 其他化合物 | ¥0.04B | 8.2% |
| 半导体光刻胶光引发剂 | ¥0.03B | 5.7% |
| 其他(补充) | ¥0.00B | 0.3% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.43B | 81.1% |
| R&D | ¥0.05B | 9.9% |
| SG&A | ¥0.06B | 11.7% |
| Tax & other | ¥0.00B | 0.5% |
| Item | Amount |
|---|---|
| Total assets | ¥3.27B |
| Total liabilities | ¥1.31B |
| Shareholders' equity | ¥1.97B |
| Equity / assets | 60.1% |
| Operating cash flow | ¥0.05B |
| Capital expenditure | ¥0.02B |
| Free cash flow | ¥0.03B |
| Cash conversion (OCF / net income) | -115% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
*ST益通 ・ 富临精工 ・ 金石亚药 ・ 中泰股份 ・ 广生堂 ・ 清水源 ・ 鹏辉能源 ・ 美康生物 ・ 运达科技 ・ 鲍斯股份 ・ 金雷股份 ・ 双杰电气
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies